Is ALPN A Good Stock To Buy Now?
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Alpine Immune Sciences Inc. (ALPN)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 3,670,955 | $32,268 | 0.4% | |
| 2. | Frazier Healthcare Partners Alan Frazier | 2,571,450 | $22,603 | 2.02% | |
| 3. | Farallon Capital Thomas Steyer | 741,290 | $6,516 | 0.04% | |
| 4. | EcoR1 Capital Oleg Nodelman | 741,290 | $6,516 | 0.46% | |
| 5. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 494,190 | $4,344 | 1.21% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.03 | 10,000 | Director | 25,000 | 2020-11-19 | Filing | |
| $4.95 | 10,000 | Officer | 10,000 | 2019-05-30 | Filing | |
| $5.37 | 372,439 | Large Shareholder, Director | 3,670,955 | 2019-01-18 | Filing | |
| $5.37 | 372,439 | Large Shareholder, Director | 3,670,955 | 2019-01-18 | Filing | |
| $5.37 | 190,875 | Large Shareholder | 3,994,781 | 2019-01-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.25 | 600,000 | Large Shareholder, Director | 3,070,955 | 2020-12-28 | Filing | |
| $14.25 | 600,000 | Large Shareholder, Director | 3,070,955 | 2020-12-28 | Filing | |
| $5.85 | 25,000 | Large Shareholder | 137,728 | 2019-02-08 | Filing | |
| $2.27 | 6,687 | Officer | 11,368 | 2017-01-04 | Filing | |
| $7.96 | 5,820 | Officer | 12,236 | 2016-10-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 17,013 | $214 | 0.09% | |
| 2. | 10,445 | $132 | 0.01% |
News See All
Hedge Funds Never Been Less Bullish On Alpine Immune Sciences, Inc. (ALPN)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW)....
Is Alpine Immune Sciences, Inc. (ALPN) A Good Stock To Buy?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards...
13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d‑1(e), 240....
13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d‑1(e), 240....
13D Filing: James E. Flynn and Alpine Immune Sciences Inc. (ALPN)
933,100 (comprised of shares held by Deerfield Special Situations Fund, Deerfield Private Design, Deerfield Private Design International, Deerfield Private Design II and Deerfield Private Design International...
Billionaire Hedge Funds
